T-cell lymphoma (PTCL and CTCL)

Clinical trials for T-cell lymphoma (PTCL and CTCL) explained in plain language.

Never miss a new study

Get alerted when new T-cell lymphoma (PTCL and CTCL) trials appear

Sign up with your email to follow new studies for T-cell lymphoma (PTCL and CTCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells target CD5 in Hard-to-Treat T-Cell lymphomas

Cure Recruiting now

Researchers are testing a new immune cell therapy called CD5 CAR-T in people with mature T-cell lymphomas that have come back or stopped responding to standard treatment. The trial enrolls about 36 participants, ages 14 to 70, who have few remaining options. Participants receive …

Matched conditions: T-CELL LYMPHOMA (PTCL AND CTCL)

Phase 1/2 • Sponsor: Beijing GoBroad Hospital • Aim: Cure

Last updated Sep 13, 2026 00:00 UTC

T-cell lymphoma (PTCL and CTCL)

Get alerted when new T-cell lymphoma (PTCL and CTCL) trials appear

Engineered immune cells target CD5 in Hard-to-Treat T-Cell lymphomas